Understand! and nothing to do with analyst’s price targets
Those who were adamant of well beyond $50/ ie BB; Marzan etc when too many were overly Ebullient to the point of either or BOTH doing call options and using their Margin Buying Power:
When I get a chance will post those pageS highlighting the above!
NONE of that IMHO was a wise move as history has demonstrated!
That was WHEN the shares were $22 plus : wasn’t that long ago: June??
ALL of the above was the view I harborED but did NOT want to post Can’t deal with Tidal Waves!
North I just want to get past the FDA overhang and then I feel like the company has no limits. But I am incredibly gun shy since October 2013 and all the stuff they have pulled between then and now.
If we can finagle an expanded label and avoid some capricious CRL I can see this company becoming huge. I just wish I had more faith that the FDA was going to shoot straight with the company.
Market Data 
Markets 
AI
